Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6.18B
Enterprise Value5.91B
P/E Ratio73.68
PEG Ratio-7.37
Price/Sales Ratio6.89
Price/Book Ratio3.14
Enterprise/Revenue6.56
Enterprise/EBITDA43.68

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.09
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.04

Income Statement

Revenue827.14M
Revenue/Share1.9
Gross Profit474.67M
EBITDA165.69M
Net Income65.09M
Diluted EPS0.16

Balance Sheet

Total Cash647.98M
Total Cash/Share1.55
Total Debt41.76M
Total Debt/Equity0.02
Current Ratio4.65
Book Value Per Share4.18

Price History

52-Week Change-24.23
52-Week High18.47
52-Week Low11.42
Moving Average 50 Days14.06
Moving Average 200 Days14.14

Statistics

Average Volume12.31M
Shares Outstanding417.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.08
Trailing Annual Dividend Yield0.57
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD